Barinthus Biotherapeutics plc. CEO William Enright's 2023 pay slips 13% to $1.8M
Barinthus Biotherapeutics plc. reports 2023 executive compensation
By ExecPay News
Published: March 22, 2024
Barinthus Biotherapeutics plc. reported fiscal year 2023 executive compensation information on March 22, 2024.
In 2023, three executives at Barinthus Biotherapeutics plc. received on average a compensation package of $1.4M, a 25% increase compared to previous year.
William Enright, Chief Executive Officer, received $1.8M in total, which decreased by 13% compared to 2022. 46% of Enright's compensation, or $842K, was in option awards. Enright also received $308K in non-equity incentive plan, $610K in salary, as well as $51K in other compensation.
Nadège Pelletier, Chief Scientific Officer, received a compensation package of $1.7M. 67% of the compensation package, or $1.1M, was in option awards.
Graham Griffiths, Chief Business Officer, earned $731K in 2023, a 3% decrease compared to previous year.